7–8 Jul 2025
Caritas Tagungszentrum Freiburg
Europe/Berlin timezone

Decoding the spatial architecture of integrated electrophysiological and transcriptomic diversity in malignant brain tumors

8 Jul 2025, 10:30
15m
Plenum 110 (Caritas Tagungszentrum Freiburg)

Plenum 110

Caritas Tagungszentrum Freiburg

Wintererstr. 17-19 79104 Freiburg
Pillar 2: Diagnostic Innovations & Molecular Prevention

Description

Glioma cells form synaptic connections with neurons, facilitating tumor progression and therapeutic resistance, yet the microenvironmental drivers of this synaptogenesis remain unclear. To investigate the mechanisms regulating neuron-glioma connectivity, we developed ElectroGenomics, an integrative spatial electrophysiology and transcriptomics approach combining high-density multielectrode array (HD-MEA) recordings, spatial transcriptomics, retrograde tracing, and graph-based network analysis. Applying this framework across human cortical slice cultures and murine glioma models, we found that tumor infiltration induces localized peritumoral hyperexcitability alongside inflammatory activation of microglia. In particular, inflammatory SPP1+/TREM2+ microglia, resembling damage-associated states observed in stroke and trauma, were found to drive BDNF-mediated synaptogenesis and facilitate neuron-tumor network formation through close spatial interactions with NPC/OPC-like tumor cells and sprouting neurons. Using optogenetic stimulation of cortical neurons in a patient-derived xenograft model, we confirmed that increased neuronal activity promotes the recruitment and activation of SPP1+ microglia specifically within the tumor-infiltrative regions. Pathway analysis further identified STAT3 signaling as a central driver of this inflammatory microglial phenotype. Pharmacological inhibition of STAT3 signaling or depletion of microglia significantly disrupted neuron-glioma connectivity and reduced neural circuit integration in human neocortical slice models. Complementary functional calcium imaging demonstrated that STAT3 inhibition led to decreased intratumoral signaling and diminished neuron-glioma synapse formation. Together, our study identifies inflammatory SPP1+/TREM2+ microglia as key regulators of neuron-glioma synapse formation and highlights the STAT3 pathway as a promising therapeutic target to disrupt glioma integration into brain circuitry.

Preferred type of presentation

Primary author

Elena Grabis (Universitätsklinik Freiburg, Klinik für Neurochirurgie, MILO Lab)

Co-authors

Abdelhamid Sta (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Prof. Adam Sonabend (Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, and Malnati Brain Tumor Institute, Northwestern Medicine, Chicago, USA) Andreas Vlachos (Department of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany) Anna Golebiewska (NORLUX Neuro-Oncology Laboratory, Department of Cancer Research, Luxembourg Institute of Health (LIH), Luxembourg) Ata Merdan (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Atique Ahmed (Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, and Malnati Brain Tumor Institute, Northwestern Medicine, Chicago, USA) Catalina Lee Chang (Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, and Malnati Brain Tumor Institute, Northwestern Medicine, Chicago, USA) Daniel Delev (Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, Erlangen, Germany) Dieter Henrik Heiland (Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, Erlangen, Germany) Dolores Hambardzumyan (Icahn School of Medicine at Mount Sinai, Departments of Oncological Sciences and Neurosurgery, New York City, United States) Ekin Reyhan (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany) Florian Putz (Department of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, Erlangen, Germany) Franz Ricklefs (Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany) Georg Kastner (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Ms Giulia Villa (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Ingmar Bluemcke (Institute of Neuropathology, University of Erlangen, Germany) Dr Jakob Straehle (Center for Advanced Surgical Tissue Analysis (CAST), Faculty of Medicine, University of Freiburg, Freiburg, Germany) Jan Kueckelhaus (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Jasim Kada Benotmane (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Jean-Philipp Waldmann (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Juergen Beck (Department of Neurosurgery, Medical Center - University of Freiburg, Freiburg, Germany) Dr Junyi Zhang (Microenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany) Levi van Hiftje (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Dr Louis Hilfiger (Department of Neuroanatomy, Institute of Anatomy and Cell Biology, Faculty of Medicine, University of Freiburg, Freiburg, Germany) Lucas Hoffmann (Institute of Neuropathology, University of Erlangen, Germany) Lynn Menzl (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Marco Mühlbauer (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Marco Prinz Michelle Monje (Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA) Dr Nicolas Neidert (Microenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany) Oliver Schnell (Department of Neurosurgery, University Hospital Erlangen, Friedrich-Alexander University Erlangen Nuremberg, Erlangen, Germany) Philipp Heinrichs (Microenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany) Rebecca Mancusi (Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA) Dr Richard Drexler (Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA) Roman Sankowski (Institute of Neuropathology, University of Freiburg, Germany) Sebastian Lillo (University of Bordeaux, CNRS, IBGC, Bordeaux, France) Svenja K Tetzlaff (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany) Tao Peng (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Dr Thomas Daubon (University of Bordeaux, CNRS, IBGC, Bordeaux, France) Varun Venkataramani (Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany) Dr Yahaya A Yabo (Microenvironment and Immunology Research Laboratory, Friedrich-Alexander Universität Nürnberg-Erlangen, Erlangen, Germany) Youran Kong (Microenvironment and Immunology Research Laboratory, Medical Center - University of Freiburg, Freiburg, Germany)

Presentation materials

There are no materials yet.